<DOC>
	<DOCNO>NCT02931266</DOCNO>
	<brief_summary>Prospective , multicenter non comparative observational study ( post-market clinical follow-up ) .</brief_summary>
	<brief_title>PASS MIS® Post-market Clinical Follow-up</brief_title>
	<detailed_description>Patients operate PASS MIS® manufacture MEDICREA® INTERNATIONAL July 2016 July 2017 . The inclusion period 12 month follow-up 24 month</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Spinal Fractures</mesh_term>
	<criteria>Patient need operate treat fracture lumbar and/or thoracic spine PASS MIS® device MEDICREA® Patient &gt; 18years Patient mature skeleton Patient able understand protocol plan visit Patient able complete selfadministered questionnaire Patient sign informed consent form Patient present medical indication thoracolumbar fracture Patient unable refuse sign inform consent form Patient unable complete selfadministered questionnaire Patient judge noncompliant investigator able come back followup visit Patient need receive receive open procedure Patient implant PASS MIS® system Pregnant woman intend get pregnant within next 2 year surgery Patient contraindication radiographies Local infectious state Allergy intolerance material , suspect know Any contraindication present notice product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>